MEDICINOVA, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
MEDICINOVA, INC. (MNOV) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$8.58 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-04-25.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-04-25
- MEDICINOVA, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2018-03-31 was -$8.58K.
- MEDICINOVA, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$17.64K.
- MEDICINOVA, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was -$33.71K.
- MEDICINOVA, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-06-30 was -$11.13K.
- MEDICINOVA, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$84.48K.
- MEDICINOVA, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$2.32K.
- MEDICINOVA, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$3.52K.
- MEDICINOVA, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was -$36.75K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2018-03-31 | -$8.58K 10-Q · filed 2018-04-25 | |||
| 2016-12-31 | -$17.64K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | -$51.35K derived: sum of 2 quarters · filed 2018-02-13 | -$62.48K derived: sum of 3 quarters · filed 2018-02-13 | -$84.48K 10-K · filed 2018-02-13 |
| 2016-09-30 | -$33.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-23 | -$44.84K derived: sum of 2 quarters · filed 2017-10-23 | -$66.84K 10-Q · filed 2017-10-23 | -$66.84K derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-06-30 | -$11.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-26 | -$33.13K 10-Q · filed 2017-07-26 | -$33.13K derived: sum of 3 quarters · filed 2018-02-13 | |
| 2016-03-31 | -$22.00K 10-Q · filed 2017-04-26 | -$22.00K derived: sum of 2 quarters · filed 2018-02-13 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | -$2.32K 10-K · filed 2018-02-13 | ||
| 2015-09-30 | -$2.32K 10-Q · filed 2016-10-25 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $0.00 derived: sum of 2 quarters · filed 2017-02-14 | $0.00 derived: sum of 3 quarters · filed 2017-02-14 | -$3.52K 10-K · filed 2017-02-14 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $0.00 derived: sum of 2 quarters · filed 2015-10-29 | -$3.52K 10-Q · filed 2015-10-29 | -$15.76K derived: sum of 4 quarters · filed 2015-10-29 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | -$3.52K 10-Q · filed 2015-07-30 | -$15.76K derived: sum of 3 quarters · filed 2015-07-30 | -$755.00 derived: sum of 4 quarters · filed 2015-07-30 |
| 2014-03-31 | -$3.52K 10-Q · filed 2015-05-11 | -$15.76K derived: sum of 2 quarters · filed 2015-05-11 | -$755.00 derived: sum of 3 quarters · filed 2015-05-11 | -$45.08K derived: sum of 4 quarters · filed 2015-05-11 |
| 2013-12-31 | -$12.24K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $2.77K derived: sum of 2 quarters · filed 2015-03-12 | -$41.55K derived: sum of 3 quarters · filed 2015-03-12 | -$36.75K 10-K · filed 2015-03-12 |
| 2013-09-30 | $15.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | -$29.31K derived: sum of 2 quarters · filed 2014-11-13 | -$24.51K 10-Q · filed 2014-11-13 | |
| 2013-06-30 | -$44.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | -$39.52K 10-Q · filed 2014-08-13 | ||
| 2013-03-31 | $4.80K 10-Q · filed 2014-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |